Wird geladen...

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

We herein report a case of congestive heart failure which developed during osimertinib treatment. A 78-year-old woman presented with mild exertional dyspnea three weeks after starting osimertinib for the treatment of epidermal growth factor receptor (EGFR) T790M-positive non-small cell lung cancer....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Intern Med
Hauptverfasser: Watanabe, Hiromi, Ichihara, Eiki, Kano, Hirohisa, Ninomiya, Kiichiro, Tanimoto, Mitsune, Kiura, Katsuyuki
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Japanese Society of Internal Medicine 2017
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596283/
https://ncbi.nlm.nih.gov/pubmed/28781309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.8344-16
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!